
Anjalee Khemlani
@AnjKhem
Followers
10K
Following
40K
Media
2K
Statuses
23K
Senior Health Reporter @YahooFinance Information is my oxygen| Also on sky| Sig anjkhem.01
New York, NY
Joined December 2011
RT @matthewherper: “The executive power grab, which experts expect to be challenged in court, is likely to have massive and immediate impac….
statnews.com
A sweeping new executive order seeks to transform how the federal government awards billions of dollars in research grants
0
5
0
BofA analysts this AM on $LLY. “results not disastrous, but stock reaction was.”.
$LLY stock diving despite a solid earnings beat, all of it GLP-1 related. Reasons: .•11% weight loss and 25% dropout rate in highest dose for much -awaited obesity pill, orforglipron.•Lower pricing resulting in 8% offset of revenues from Zepbound, Mounjaro
0
0
0
RT @bobjherman: It's official: DOJ is allowing UnitedHealth Group to acquire Amedisys, as long as it sells more home health and hospice ass….
statnews.com
The Amedisys deal would add to UnitedHealth's home and hospice-care operations.
0
5
0
RT @mroliverbarnes: NEW: Novartis has made a takeover approach for rare disease-focused biotech Avidity Biosciences, as Big Pharma continue….
ft.com
[FREE TO READ] Pharma companies seek deals to replace revenue they will lose due to looming patent cliffs
0
3
0
$NVO missed Wall Street estimates on earnings -- a week after signaling it would with a downward revision of its 2025 guidance. DTC market penetration via NovoCare for cash patients is 10%.
finance.yahoo.com
Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.
1
0
1
RT @matthewherper: Kennedy cancels $500 million in mRNA vaccine contracts
statnews.com
Vaccine experts and people steeped in pandemic preparedness expressed horror at the news that RFK Jr. has shut the door in U.S. investment in mRNA vaccine research.
0
6
0
A worthy re-up:.Healthcare worst-performing S&P 500 subsector year to date.
finance.yahoo.com
Tariffs, executive orders, and FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's actions are pressuring a historically "safe" sector.
1
0
1
RT @ashleycapoot: New: Linda Yaccarino, the former chief executive of Elon Musk’s social media platform X, is pivoting into health care. S….
cnbc.com
Yaccarino stepped down as CEO of Elon Musk's social media platform X in July.
0
2
0